These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 12596194)

  • 1. Vancomycin assembly: nature's way.
    Hubbard BK; Walsh CT
    Angew Chem Int Ed Engl; 2003 Feb; 42(7):730-65. PubMed ID: 12596194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycopeptide and lipoglycopeptide antibiotics.
    Kahne D; Leimkuhler C; Lu W; Walsh C
    Chem Rev; 2005 Feb; 105(2):425-48. PubMed ID: 15700951
    [No Abstract]   [Full Text] [Related]  

  • 3. [Non-natural aglycones of glycopeptide antibiotics of the vancomycin group. Synthesis and antibacterial activity].
    Pavlov AIu; Olsuf'eva EN; Miroshnikova OV; Reznikova MI; Lazhko EI; Malabarba A; Ciabatti R; Preobrazhenskaia MN
    Bioorg Khim; 1997 May; 23(5):410-21. PubMed ID: 9290051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent advances in the study of synthesis and activity of vancomycin derivatives].
    Chen YY; Liu G
    Yao Xue Xue Bao; 2007 May; 42(5):463-9. PubMed ID: 17703765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biosynthesis of glycopeptide antibiotics--a model for complex, non-ribosomally synthesized, peptidic secondary metabolites.
    Süssmuth RD; Wohlleben W
    Appl Microbiol Biotechnol; 2004 Jan; 63(4):344-50. PubMed ID: 14564489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of glycopeptide-resistance gene in response to vancomycin and teicoplanin in the cardiac vegetations of rabbits infected with VanB-type Enterococcus faecalis.
    Lefort A; Arthur M; Depardieu F; Chau F; Pouzet C; Courvalin P; Fantin B
    J Infect Dis; 2004 Jan; 189(1):90-7. PubMed ID: 14702158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
    J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacterial resistance to vancomycin and other glycopeptide antibiotics: an emerging threat].
    Kłoszewska M; Markiewicz Z
    Postepy Biochem; 1999; 45(2):122-36. PubMed ID: 10581636
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.
    Lundstrom TS; Sobel JD
    Infect Dis Clin North Am; 2004 Sep; 18(3):651-68, x. PubMed ID: 15308280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous expression of glycopeptide resistance vanHAX gene clusters from soil bacteria in Enterococcus faecalis.
    Hasman H; Aarestrup FM; Dalsgaard A; Guardabassi L
    J Antimicrob Chemother; 2006 Apr; 57(4):648-53. PubMed ID: 16476725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance.
    Hong HJ; Hutchings MI; Neu JM; Wright GD; Paget MS; Buttner MJ
    Mol Microbiol; 2004 May; 52(4):1107-21. PubMed ID: 15130128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glycopeptide antibiotics resistance mechanism as the basis for novel derivatives development capable to overcome resistance].
    Trenin AS; Olsuf'eva EN
    Bioorg Khim; 1997 Nov; 23(11):851-67. PubMed ID: 9518425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biosynthesis of vancomycin-type glycopeptide antibiotics--a model for oxidative side-chain cross-linking by oxygenases coupled to the action of peptide synthetases.
    Bischoff D; Bister B; Bertazzo M; Pfeifer V; Stegmann E; Nicholson GJ; Keller S; Pelzer S; Wohlleben W; Süssmuth RD
    Chembiochem; 2005 Feb; 6(2):267-72. PubMed ID: 15651041
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria.
    Lu J; Yoshida O; Hayashi S; Arimoto H
    Chem Commun (Camb); 2007 Jan; (3):251-3. PubMed ID: 17299629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex oxidation chemistry in the biosynthetic pathways to vancomycin/teicoplanin antibiotics.
    Widboom PF; Bruner SD
    Chembiochem; 2009 Jul; 10(11):1757-64. PubMed ID: 19533699
    [No Abstract]   [Full Text] [Related]  

  • 16. Chapter 18. Molecular genetic approaches to analyze glycopeptide biosynthesis.
    Wohlleben W; Stegmann E; Süssmuth RD
    Methods Enzymol; 2009; 458():459-86. PubMed ID: 19374994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First principles investigation of vancomycin and teicoplanin binding to bacterial cell wall termini.
    Lee JG; Sagui C; Roland C
    J Am Chem Soc; 2004 Jul; 126(27):8384-5. PubMed ID: 15237988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin resistance: are there better glycopeptides coming?
    Linden PK
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):917-28. PubMed ID: 19053904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycopeptide-resistance transferability from vancomycin-resistant enterococci of human and animal source to Listeria spp.
    de Niederhäusern S; Sabia C; Messi P; Guerrieri E; Manicardi G; Bondi M
    Lett Appl Microbiol; 2004; 39(6):483-9. PubMed ID: 15548299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of glycopeptide antibiotics.
    Finch RG; Eliopoulos GM
    J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii5-13. PubMed ID: 15750036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.